Table 4: Descriptive Statistics for Pain Catastrophizing subscales at Baseline, Week 1, Week 2, and Week 3.
Assessment | ||||||
Variable | Group | n | BaselineM (SD) | Week 1M (SD) | Week 2M (SD) | Week 3M (SD) |
Rumination | Experimental | 9 | 8.22 (4.24) | 5.67 (3.87) | 5.78 (3.73) | 3.89 (3.92) |
Placebo | 9 | 5.33 (4.18) | 5.22 (4.15) | 4.78 (4.87) | 5.11 (4.86) | |
Control | 10 | 8.90 (4.07) | 7.30 (4.76) | 4.50 (4.30) | 6.20 (4.54) | |
Magnification | Experimental | 9 | 5.33 (2.78) | 3.67 (2.60) | 3.78 (2.28) | 2.67 (2.06) |
Placebo | 9 | 3.44 (3.78) | 3.67 (3.81) | 3.56 (4.00) | 3.33 (4.00) | |
Control | 10 | 5.30 (2.91) | 4.80 (3.85) | 4.60 (3.06) | 5.30 (3.86) | |
Helplessness | Experimental | 9 | 8.22 (3.80) | 4.44 (2.51) | 5.00 (4.18) | 3.56 (4.85) |
Placebo | 9 | 6.44 (6.02) | 4.56 (5.94) | 4.56 (5.55) | 4.11 (5.30) | |
Control | 10 | 8.00 (4.47) | 6.70 (5.50) | 5.00 (3.97) | 5.70 (6.08) |
Note: Total pain catastrophizing scores range from a low of 0 to a high of 52; rumination subscale a low of 0 to a high of 16; magnification subscale a low of 0 to a high of 12; helplessness subscale a low of 0 to a high of 24.